Urology · Palm Springs, CA
NPI
1700843174
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
555 E Tachevah Dr, Ste 2w-101
Palm Springs, CA, 92262
Phone (760) 320-6005
Groups this clinician bills Medicare through
Medicare paid, 2024
$144K
3,646 services
Medicare patients, 2024
492
Average age 77
Drug cost, 2024
$312K
5,830 prescriptions
Company payments, 2024
$29.93
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brad A Wolfson was code 81000 (clinical chemistry), 646 times for 413 patients. In total Brad A Wolfson billed 3,646 services in 58 codes, and Medicare paid $144K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-02-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81000 Clinical Chemistry | Office | 646 | 413 | $3.94 | $2,545 |
| 99213 Office E&M - Established | Office | 489 | 359 | $61.23 | $30K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 206 | 24 | $138.03 | $28K |
| 76705 Ultrasound - Abdomen and Pelvis | Office | 190 | 182 | $59.51 | $11K |
| 51741 Test - Miscellaneous | Office | 190 | 182 | $9.83 | $1,868 |
| 99214 Office E&M - Established | Office | 112 | 78 | $86.81 | $9,723 |
| 52000 Cystourethroscopy | Office | 66 | 53 | $174.85 | $12K |
| 51798 Ultrasound - Nonspecific | Office | 63 | 54 | $8.00 | $504 |
| 99231 Hospital E&M - Subsequent | Facility | 61 | 23 | $36.32 | $2,216 |
| 99204 Office E&M - New | Office | 55 | 55 | $102.69 | $5,648 |
| 96402 Chemotherapy Administration | Office | 42 | 22 | $26.94 | $1,132 |
| 99222 Hospital E&M - Initial | Facility | 34 | 33 | $97.45 | $3,313 |
| 99232 Hospital E&M - Subsequent | Facility | 32 | 19 | $59.26 | $1,896 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 30 | 30 | $11.27 | $338 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 29 | 29 | $79.69 | $2,311 |
By year: 2022 $169K for 3,737 services; 2023 $160K for 3,433 services; 2024 $144K for 3,646 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81000 Clinical Chemistry | 646 | 413 | $3.94 | $2,545 |
Medicare prescription drug claims, 2024
In 2024, the drug Brad A Wolfson prescribed most often to Medicare patients was Finasteride, with 1,355 prescriptions and refills. In total Brad A Wolfson wrote 5,830 Medicare prescriptions that cost $312K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Finasteride Generic | 1,355 | 3,634 | 393 | $16K |
| Tamsulosin Hcl Generic | 1,256 | 3,228 | 375 | $19K |
| Ciprofloxacin Hcl Generic | 473 | 477 | 347 | $2,012 |
| Bicalutamide Generic | 368 | 958 | 128 | $15K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 264 | 680 | 67 | $8,238 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 253 | 601 | 84 | $4,250 |
| Estradiol Generic | 243 | 482 | 112 | $15K |
| Methenamine Hippurate Generic | 209 | 428 | 58 | $12K |
| Myrbetriq Mirabegron | 193 | 325 | 45 | $146K |
| Testosterone Generic | 114 | 134 | 24 | $10K |
| Potassium Citrate Er Potassium Citrate | 95 | 212 | 29 | $8,947 |
| Terazosin Hcl Generic | 88 | 226 | 27 | $2,122 |
| Levofloxacin Generic | 83 | 83 | 70 | $302 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 81 | 81 | 64 | $301 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 79 | 79 | 76 | $382 |
Brand drugs: 257 claims; generic drugs: 5,561 claims; opioid claims: 81.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Brad A Wolfson $29.93 ($29.93 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $29.93.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $29.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.